202 - AI Inflection, Payer Chaos, and the Healthcare Energy Bind | Health:Further

Vic and Marcus discuss the yen carry trade and its implications for the Federal Reserve, the rapid transformation of the U.S. economy by AI, and the growing risks surrounding AI investment and infrastructure. They cover major healthcare and biotech funding, including LifeMine Therapeutics, Function Health, and Quant Health, along with the Senate confirmation of Dr. Erica Schwartz as CDC director and a 2.3% Medicare hospital payment increase for 2027. The episode also examines CVS Health's GLP-1 partnership with Eli Lilly, Amazon's $50-a-month GLP-1 offering for Medicare patients, rising numbers of uninsured Americans, and a potential AstraZeneca-Bristol Myers Squibb merger. They also discuss extreme heat's growing impact on Americans, rising heart disease rates among younger women, patients using AI to interpret medical results, DeepSeek's dramatically lower AI costs, AI models behaving deceptively during testing, and the accelerating path toward recursive self-improvement and AGI.Story Lineup1 — In This Economy1:30 - Story 1: https://www.wsj.com/economy/central-banking/scott-bessents-yen-trade-has-unintended-consequences-for-the-markets-5297044b?mod=Searchresults&pos=1&page=16:57 - Story 2: The AI Boom Is Transforming the American Economy—and Healthcare Must Contend With Energy Constraints  [WSJ]2 — VC Deal Review15:36 - Story 1: LifeMine Therapeutics Raises $188M Series E From Gates and Bezos to Revive Fungal-Therapeutic Platform  [Fierce Biotech]16:23 - Story 2: Function Health Raises $450M Growth Round to Expand Preventive Care Lab and Imaging Footprint  [MedCity News]17:48 - Story 3: QuantHealth Raises $45M Series B to Reduce Pharma Trial Failure via AI Clinical-Trial Simulation  [MedCity News]3 — Policy20:30 - Story 1: Senate Confirms Dr. Erica Schwartz as CDC Director in Party-Line Vote; First Permanent Director in Year  [Becker's Hospital Review]22:17 - Story 2: Hospital Price Caps Gain Momentum Across Multiple States, Making Affordability a CEO Accountability Issue  [Becker's Hospital Review]4 — Health Payors23:37 - Story 1: CVS Health Partners With Eli Lilly on GLP-1 Weight Management, Lifts Full-Year Outlook on Strong Health Plan Results  [WSJ]24:11 - Story 2: Amazon Pharmacy Now Offers GLP-1 Weight-Loss Drugs to Medicare Part D Beneficiaries at $50/Month  [WSJ]5 — Health Systems25:25 - Story 1: ACA Subsidy Expiration Drives Millions Uninsured; Hospitals Report Rising Uncompensated Care and Revenue Losses  [WSJ]6 — About Health & Us / The Clinician's Voice28:36 - Story 1: 90% of Americans Report Extreme Heat Affecting Their Health and Daily Life; Major Shift in Climate-Health Awareness  [Axios]31:46 - Story 2: Rising Cardiovascular Disease Among Young Women Examined; Prevention Strategies and Risk-Profile Shifts Discussed  [New York Times]33:05 - Story 3: One-Third of Adults Now Use AI to Interpret Medical Test Results Despite Physician Objections  [WSJ]7 — The AI Tracker34:35 - Story 1:  https://www.reuters.com/business/retail-consumer/deepseeks-new-ai-model-is-by-far-cheapest-well-known-models-run-research-firm-2026-08-03/37:44 - Story 2: OpenAI and Anthropic AI Agents Engaged in Sustained Hacking Attempts on Real Infrastructure; U.K. AI Security Institute Reports Deceptive Behavior During Safety Testing  [WSJ]41:17 - Story 3: Leading AI Architects Declare Singularity Threshold Reached; Google Signals Major Leadership Rupture as Industry Enters Intelligence-Explosion Phase  [Axios]